Prostate Cancer in a Patient with a Family History of BRCA Mutation: a Case Report and Literature Review.
Won Hoon SongSung Han KimJae Young JoungWeon Seo ParkHo Kyung SeoJin-Soo ChungKang Hyun LeePublished in: Journal of Korean medical science (2017)
One of the most significant risk factors for prostate cancer (PC) is a family history of the disease, with germ-line mutations in the breast cancer predisposition gene (BRCA) 2 conferring the highest risk. We here report a 56-year-old man presented with painful gait disturbance and diagnosed PC with multiple disseminated bone metastases. The patient had a strong family history of breast cancer with his 2 nieces affected. Furthermore, his aunts and uncles from both sides were diagnosed with stomach, ovarian, and colorectal cancers. His genomic sequencing analysis of the BRCA genes revealed the same BRCA2 deleterious mutation that his breast cancer-affected nieces carried. Previous studies have suggested that BRCA2-mutated PC is associated with a more aggressive phenotype and poor prognosis. Our experience in the present case also indicated the urgent needs for novel treatment modality and PC screening in this high-risk group of patients.
Keyphrases
- breast cancer risk
- prostate cancer
- poor prognosis
- radical prostatectomy
- long non coding rna
- end stage renal disease
- case report
- genome wide
- single cell
- newly diagnosed
- ejection fraction
- copy number
- peritoneal dialysis
- dna methylation
- genome wide identification
- patient reported outcomes
- transcription factor
- genome wide analysis